| |
original article |
Date |
Title |
Authors All Authors |
| 1 |
[GO] |
2021―Sep―03 |
Prospect of Ion Channel Inhibitors and Cholesterol Lowering Drugs to Combat COVID-19 |
Tewari DN, Chakrabarti AK, Dutta S |
| 2 |
[GO] |
2021―Sep―03 |
Transcutaneous Vagus Nerve Stimulation is Associated with Lower Mechanical Ventilation and Mortality in COVID-19 Patients |
Nemechek P, Antonelli G, Braida A |
| 3 |
[GO] |
2021―Sep―03 |
Comparison of Disease Nature of MERS, SARS-CoV-1, and SARS-CoV-2: A Review |
El Hajj S, Sacre Y, Barbour EK, Kumosani T, Amr G, Karameh W, et al. (+2) Daher M, Farah D |
| 4 |
[GO] |
2021―Mar―18 |
The Perfect Storm Review: Immune Dysregulation in Severe COVID-19 and the Possible Role of Mast Cell-Vitamin D Interactions |
Houldsworth A |
| 5 |
[GO] |
2021―Mar―18 |
Bus Based Mobile Virus Diagnostic Laboratory for COVID-19 Sample Collection and Testing in Remote Areas |
Rao YS, Rao SR |
| 6 |
[GO] |
2021―Mar―18 |
Bayesian Model for Covid-19 to Achieve Immunity by Parsimony of Exponential Functions Minimizing the Inoculum |
Lamothe N, Lamothe M, Lamothe D, Sierra C, Gonzalez- Tellez-Giron CH, Rodas VH, et al. (+10) Lamothe A, Sanchez-Montiel J, Lamothe C, Galicia H, Perez-Avalos JL, Rojas O, Cazarin Z, Pena AVDL, Diaz-del Bosque A, Lamothe PJ |
| 7 |
[GO] |
2020―Nov―25 |
Compassionate Use of Opaganib for Patients with Severe COVID-19 |
Kurd R, Ben-Chetrit E, Karameh H, Bar-Meir M |
| 8 |
[GO] |
2020―Nov―25 |
Clinical Features and Follow-Up of SARS-Cov-2 Asymptomatic Carriers |
Liu L, Yuan MJ, Hong XQ, Yu Y, Su X, Huang Y, et al. (+4) Wang X, Li S, Li X, Shi Y |
| 9 |
[GO] |
2020―Nov―25 |
Olfactory and Gustatory Dysfunction Associated with SARS-CoV-2 Infection |
Fang G, Ma X, Chen Z, Gao G, Xie W, Xie R, Zhang F |
| 10 |
[GO] |
2020―Aug―14 |
Vagus Nerve Stimulation is an Ideal Therapeutic Candidate for COVID-19 Infection |
Nemechek P |
| 11 |
[GO] |
2020―Jul―29 |
COVID-19 Outbreak in Pakistan; a Situational Analysis |
Noreen N, Siddiqui SW, Niazi SUK, Khudaidad F, Khan NU, Dil S, et al. (+2) Khan MA, Naveed I |
| 12 |
[GO] |
2020―Jun―06 |
Use of CRISPR to Enhance and Combat Human Viral Infections as HIV and SARS-Cov-2 |
Ataa AMA, Ataa AMA |
| 13 |
[GO] |
2020―May―08 |
Description of 29, COVID-19 Patients from District Nowshera, Pakistan |
Khan H |
|
